DGII · Digi International Inc.

Current Thesis

Digi International's recurring-revenue pivot supports a tentative recovery case, resolved by a weekly close above $76 before a daily close below $69.36. These are separate recovery conditions: the original August re-rating thesis already failed when the 2026-09-04 close of $69.36 breached its published $76 threshold and the 2026-08-05 pre-results close of $72.75. The new recovery case does not reverse that outcome.

The measured improvement since the previous note is the 2026-09-18 adjusted close of $72.13, compared with $69.36 on 2026-09-04. The 14-day relative strength index (RSI) rose from 22.0 to 40.2 across those observations, but price remains below $72.75. As an inference about the August re-rating, the narrative is dead — the 2026-09-04 breakdown remains unrepaired at the 2026-09-18 close. The limited observations do not establish a durable base.

The operating argument remains Digi's transition from hardware sales toward annual recurring revenue (ARR): management reported $191 million of ARR and raised fiscal 2026 revenue guidance to $529 million–$533 million on 2026-08-05. Subsequent developments are mixed: MarketBeat records a Weiss Ratings downgrade on 2026-09-10, while Digi announced a Particle product showcase on 2026-09-17. Neither supplies a new quarterly revenue result. Digi results, MarketBeat rating history, Particle announcement.

Bullish and bearish views on Digi International Inc.

The model's bull view on Digi International Inc. (DGII), in brief: Recurring revenue supports the transition. The bear view: The prior breakdown remains unrepaired. The 2026-09-18 close of $72.13 remains below the 2026-08-05 pre-results close of $72.75 and the previous thesis threshold of $76. The latest adjusted price series places the shares 15.4% below their $85.24 trailing-year high. Acquisitions… Both cases follow in full.

Bull Case

• Recurring revenue supports the transition. Digi's 2026-08-05 results put quarter-end ARR at $191 million, up 52% year over year. That is the operating evidence behind the recovery hypothesis; subsequent ARR contraction would weaken it.
• Profitability accompanied reported growth. The 2026-08-05 results showed a 64.8% gross margin and a 29.1% adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) margin. These reported outcomes support the recurring-revenue argument, although they do not establish organic growth.
• Quarterly guidance provides a test. On 2026-08-05, Digi guided fiscal fourth-quarter revenue to $138 million–$142 million and adjusted earnings per share to $0.75–$0.78. Revenue below the lower end would contradict the near-term operating case. Digi results and guidance.

Bear Case

• The prior breakdown remains unrepaired. The 2026-09-18 close of $72.13 remains below the 2026-08-05 pre-results close of $72.75 and the previous thesis threshold of $76. The latest adjusted price series places the shares 15.4% below their $85.24 trailing-year high.
• Acquisitions obscure the organic contribution. The 2026-08-05 call figures include Jolt and Particle, while the organic growth split was not disclosed in the cited call account. Reported ARR growth of 52% therefore cannot establish an equivalent rate of internally generated growth.
• A subsequent rating weakened. MarketBeat records Weiss Ratings moving Digi from B- to C+ on 2026-09-10. This supersedes the previous note's blanket statement that no downgrade had occurred; the displayed action includes no price target. MarketBeat rating history.

Setup & Price Structure

The 2026-09-18 adjusted close was $72.13, with a three-month price increase of 4.9% and RSI of 40.2. The first unrecovered reference is the $72.75 close recorded before the 2026-08-05 results. A weekly close above $76 would complete the narrower price-recovery case; $76 was the previous published thesis threshold and Piper Sandler's target dated 2026-08-06. A daily close below $69.36, the documented 2026-09-04 close, would invalidate this recovery attempt. That reference is not established as the intervening period's lowest price.

The observable coverage cluster remains the 2026-08-06 target revisions: Piper Sandler at $76, Stephens at $85 and B. Riley at $86. Those synchronized revisions show concentrated analyst attention around the earnings release; they do not measure investor ownership or retail crowding. Benzinga analyst-action history.

Current short interest, retail participation, trading-volume confirmation and moving-average distances are unavailable in the dated evidence. No crowding verdict follows from the analyst cluster alone. Evidence conviction remains low because the 2026-09-18 close has not recovered even the pre-results reference.

Catalyst Calendar (next 30 days)

• 2026-09-22–2026-09-24 — Particle showcase. Digi's 2026-09-17 announcement schedules demonstrations of embedded artificial intelligence and satellite connectivity at Embedded World North America. It discloses no revenue commitments, so the event does not itself resolve the ARR thesis. Company announcement.
• 2026-09-30 — Fiscal year-end. The reporting period closes for the $529 million–$533 million fiscal 2026 revenue guidance issued on 2026-08-05. An accounting period-end is not an earnings release; no result is established that day.
• ~2026-11-11, est. Fourth-quarter results. This date remains an estimate, outside the 2026-09-20–2026-10-20 window. Digi released the corresponding prior-year results on 2025-11-12; its financial-release calendar checked on 2026-09-20 contains no confirmed fiscal 2026 fourth-quarter announcement. Actual quarterly revenue against the $138 million–$142 million guide is the next financial test. Digi financial calendar.

What Would Change Our Mind

Loss of the documented September recovery reference would end the narrower hypothesis: a daily close below $69.36 would breach the 2026-09-04 close before a weekly recovery above $76. This is a new recovery test following an acknowledged failure, not an extension of the original invalidation threshold.

Operating evidence could separately disprove the recurring-revenue interpretation. Fiscal fourth-quarter revenue below the $138 million lower bound issued on 2026-08-05, or quarter-end ARR below the $191 million reported that day, would weaken it. A weekly close above $76 would establish price repair; confirmation of the business transition would still require subsequent financial disclosure.

Correlation Notes

The 2026-08-05 call's reported growth includes acquisitions, making company execution central to this single-name setup. The 2026-09-17 Particle announcement establishes exposure to embedded artificial intelligence products, but supplies neither a quantified artificial-intelligence revenue contribution nor a return correlation with semiconductor or satellite equities. No peer-return series accompanies the 2026-09-18 price observations, so a group-driven recovery is unsupported. Particle announcement.